These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19104418)

  • 1. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes.
    Warnock GL; Thompson DM; Meloche RM; Shapiro RJ; Ao Z; Keown P; Johnson JD; Verchere CB; Partovi N; Begg IS; Fung M; Kozak SE; Tong SO; Alghofaili KM; Harris C
    Transplantation; 2008 Dec; 86(12):1762-6. PubMed ID: 19104418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy.
    Thompson DM; Begg IS; Harris C; Ao Z; Fung MA; Meloche RM; Keown P; Meneilly GS; Shapiro RJ; Ho S; Dawson KG; Al Ghofaili K; Al Riyami L; Al Mehthel M; Kozak SE; Tong SO; Warnock GL
    Transplantation; 2008 May; 85(10):1400-5. PubMed ID: 18497678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report.
    Fung MA; Warnock GL; Ao Z; Keown P; Meloche M; Shapiro RJ; Ho S; Worsley D; Meneilly GS; Al Ghofaili K; Kozak SE; Tong SO; Trinh M; Blackburn L; Kozak RM; Fensom BA; Thompson DM
    Transplantation; 2007 Jul; 84(1):17-22. PubMed ID: 17627232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
    Lablanche S; Vantyghem MC; Kessler L; Wojtusciszyn A; Borot S; Thivolet C; Girerd S; Bosco D; Bosson JL; Colin C; Tetaz R; Logerot S; Kerr-Conte J; Renard E; Penfornis A; Morelon E; Buron F; Skaare K; Grguric G; Camillo-Brault C; Egelhofer H; Benomar K; Badet L; Berney T; Pattou F; Benhamou PY;
    Lancet Diabetes Endocrinol; 2018 Jul; 6(7):527-537. PubMed ID: 29776895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
    Maffi P; Bertuzzi F; De Taddeo F; Magistretti P; Nano R; Fiorina P; Caumo A; Pozzi P; Socci C; Venturini M; del Maschio A; Secchi A
    Diabetes Care; 2007 May; 30(5):1150-5. PubMed ID: 17259471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy.
    Thompson DM; Meloche M; Ao Z; Paty B; Keown P; Shapiro RJ; Ho S; Worsley D; Fung M; Meneilly G; Begg I; Al Mehthel M; Kondi J; Harris C; Fensom B; Kozak SE; Tong SO; Trinh M; Warnock GL
    Transplantation; 2011 Feb; 91(3):373-8. PubMed ID: 21258272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable renal function after islet transplantation: importance of patient selection and aggressive clinical management.
    Leitão CB; Cure P; Messinger S; Pileggi A; Lenz O; Froud T; Faradji RN; Selvaggi G; Kupin W; Ricordi C; Alejandro R
    Transplantation; 2009 Mar; 87(5):681-8. PubMed ID: 19295312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten years' clinical experience of fetal islet transplantation.
    Farkas G; Szabó M; Vörös P
    Transplant Proc; 1992 Dec; 24(6):2954-5. PubMed ID: 1466012
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
    J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraportal islet allografts in type I diabetes mellitus.
    Alejandro R; Burke G; Shapiro ET; Strasser S; Nery J; Ricordi C; Esquenazi V; Miller J; Mintz DH
    Transplant Proc; 1992 Jun; 24(3):959-60. PubMed ID: 1604685
    [No Abstract]   [Full Text] [Related]  

  • 16. Islet cell transplantation improves nerve conduction velocity in type 1 diabetes compared with intensive medical therapy over six years.
    Fensom B; Harris C; Thompson SE; Al Mehthel M; Thompson DM
    Diabetes Res Clin Pract; 2016 Dec; 122():101-105. PubMed ID: 27825059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
    Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
    Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation: neurophysiological and skin biopsy longitudinal analysis.
    Del Carro U; Fiorina P; Amadio S; De Toni Franceschini L; Petrelli A; Menini S; Martinelli Boneschi F; Ferrari S; Pugliese G; Maffi P; Comi G; Secchi A
    Diabetes Care; 2007 Dec; 30(12):3063-9. PubMed ID: 17804685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
    Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.